Dapsone
- Product NDC
- 13925-505
- 11-digit product format
- 139250505
- Labeler code
- 13925
- Product ID
- 13925-505_ec807b3c-14d5-47f0-a239-bff0363ec49b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Seton Pharmaceuticals
- Application
- ANDA086842
- Marketing category
- ANDA
- Marketing start
- 2016-03-10
- Marketing end
- 2026-07-31
- Substance
- DAPSONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dapsone
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DAPSONE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8W5C518302 |
| Rxcui | 197557, 197558 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 13925-505-01 | 2025-09-19 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-30 | 2025-09-19 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-01 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-30 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-01 | 2020-04-30 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-30 | 2020-04-30 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
| 13925-505-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fb89-f424-e053-dadaa90a57ce | DAPSONE Tablets, USP 25 mg & 100 mg |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13925-505-01 | Dapsone | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
| 13925-505-30 | Dapsone | 2 in 1 CARTON | TABLET | 2 | | 4 |
| 13925-505-30 | Dapsone | 15 in 1 BLISTER PACK | TABLET | 15 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13925-505 | DAPSONE TABLET [SETON PHARMACEUTICALS] | 3 | Current NDC, Legacy NDC, 3 package rows | 20200501_229af266-d901-43e2-828a-4931d1124ea3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13925-505-01 | 13925050501 | 100 TABLET in 1 BOTTLE (13925-505-01) | 100 tablet | 2016-03-10 | 2026-07-31 | No | No | Current |
| 13925-505-30 | 13925050530 | 2 BLISTER PACK in 1 CARTON (13925-505-30) > 15 TABLET in 1 BLISTER PACK | 2 blister pack | 2016-03-21 | 0000-00-00 | No | No | Current |